First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma
一线伊匹木单抗联合纳武利尤单抗对比免疫检查点抑制剂联合酪氨酸激酶抑制剂治疗中危或高危转移性透明细胞肾细胞癌患者
期刊:Journal of Kidney Cancer and VHL
影响因子:1.9
doi:10.15586/jkc.v12i2.387
Ostrowski, Micah; Jo, Yeonjung; Gebrael, Georges; Chehade, Chadi Hage; Ozay, Zeynep Irem; Nordblad, Blake; Srivastava, Ayana; Garg, Diya; Ji, Richard; Fortuna, Gliceida Galarza; Thomas, Vinay Mathew; Chigarira, Beverly; Anderson, Ethan; Agarwal, Neeraj; Maughan, Benjamin L; Swami, Umang
Checkpoint
肿瘤
肿瘤免疫
信号转导
肾癌
细胞生物学
免疫/内分泌
